New Business Opportunities in Bio/Pharma,
Medical Devices & Diagnostics

August 2017

Welcome to the August 2017 issue of PharmSource PERISCOPE

This monthly e-newsletter provides valuable insight to sales and marketing professionals who sell goods and services to bio/pharma, medical device or diagnostic companies. It helps you recognize new business opportunities and overcome sales obstacles.

Enjoy the August issue!

The PharmSource Team


Populating Your CRM with New Business Opportunities

by Blythe Moore, Director of Account Management

Integrating the PharmSource Lead Sheet leads and contacts into your company’s customer relationship management (CRM) can be an important part of following up on the targeted new business opportunities you identify.

Many companies use the Lead Sheet very efficiently by diligently tagging appropriate leads and importing selective data into their CRMs. This ensures that incoming data is relevant to… read on

PharmSource Lead Sheet
Summary of Global Clinical Pipeline Activity

Lead Type July 2017 YTD 2017
Early Development 97 768
Late Development 85 750
Biologic 81 711
Small Molecule 196 1670
Parenteral 77 752
Oral 83 652
New Financings 79 570
Total Drug Leads 366 2553
Total Device &
Diagnostic Leads
130 987

*Total leads include acquisitions/alliances, company acquisition/alliances and events.

Pipeline Tip

Rebiotix enrolls the first patient in a Phase III trial with RBX2660 for the treatment of recurrent Clostridium difficile infection:

  • Therapeutic Area: Gastrointestinal
  • Dosage Form: Liquid – Non-sterile
  • API: Biologic – Modified bacteria

Get deeper information about the likely upcoming needs of Rebiotix, its pipeline, contacts and more in the PharmSource Lead Sheet. If you’re not yet a subscriber, click here to learn more.

Follow the Money to

Bio/Pharmaceutical Opportunities

Spotlight on CymaBay Therapeutics

CymaBay Therapeutics, formerly known as Metabolex, develops drugs to treat diabetes and related metabolic disorders. They plan to raise $84.5 million in the secondary public offering period.

What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to fund general corporate purposes and for the clinical development of seladelpar… read on

Follow the Money to

Medical Device & Diagnostic Opportunities

Spotlight on SEBACIA, Inc.

SEBACIA, Inc. is a US private company that develops light-based therapies for the treatment of dermatological conditions. They raised $36 million in the completion of a mixed financing round.

What new business opportunities are most likely to surface from this? We know they plan to use the proceeds to support the US clinical trials and EU marketing efforts for thier product pipeline for the treatment of acne… read on

Dose CMOs Stuck in Idle

PharmSource’s just-released trend report, Contract Dose Manufacturing Industry by the Numbers: Composition, Size, Market Share and Outlook – 2017 Edition, reveals several factors for the dose CMO industry’s relatively poor performance in 2016:

1. Rebound in drug development since 2013 is too recent to benefit dose CMOs

2. Heavy investment in captive capacity by global bio/pharma companies

3. Declining significance of dose manufacturing in drug cost of goods as new drugs with high value APIs dominate the pipeline


Save the date!

PBOA First Annual Meeting and Conference

October 3rd and 4th at the Bethesda North Marriott in Bethesda, MD

This event is open exclusively to PBOA-member companies!

Get the insider’s view on the regulatory, legislative and market trends driving the biopharmaceutical CDMO industry.

Information on room rates and agenda will be coming soon.

PharmSource Lead Sheet

The PharmSource Lead Sheet is the industry’s definitive source for identifying targeted new business opportunities in bio/pharmaceutical companies around the world. Our dedicated research team knows how and where to find fresh, targeted leads, and we have the contact information you need to start the sales process.

Don’t be the last to learn about the latest business development opportunities. If you’re not already using the Lead Sheet, contact us today to schedule a complimentary test-drive.

See for yourself how this resource can be a vital tool for building your brand and growing your market share.

To request a test-drive today, contact Nathaniel Celentano at / 1-703-383-4903, ext. 112 (ET USA).